PALI Ready for a ride?
Swing Trading $PALI: Updated Plan for July 2025
Palisade Bio, Inc. ($PALI) dropped to $1.22 recently, now at $1.007 (July 24, 2025), signaling a swing trade setup. This biopharma stock, focused on inflammatory bowel diseases, is volatile with a micro-float and high short interest. After a 13.26% surge, is it ready for another run? Here’s the plan.
Why $PALI?
The $1.22 pullback hit a support zone ($1.20–$1.25) we discussed. X posts show trader hype with volume spikes, but poor fundamentals and biotech risks persist.
Technical Setup
At $1.007, $PALI is above its 50-day MA ($0.7258) but below its 20-day MA ($1.15). RSI is 57.20, neutral-bullish. Volume hit 11.9M vs. 418K average. Key levels: Support $0.99–$1.00, Resistance $1.18–$1.22, $1.50, Pivot $1.12.
Swing Trade Plan
Target a 1–5 day trade with 30–60% upside.
- Entry: Buy at $1.00–$1.05 or above $1.18 (>1M volume).
- Stop-Loss: $0.95 (5–8% risk).
- Take-Profit: $1.30 (30%), $1.50 (50%), $1.80 (80%).
- Risk: 1–2% of portfolio. Watch PALI-2108 news (H1 2025).
Exit Points & Probabilities
| Exit Price | Gain | Probability | Timeframe |
|---|---|---|---|
| $1.30 | 29% | 65% | 1–3 days |
| $1.50 | 49% | 45% | 3–5 days |
| $1.80 | 79% | 25% | 5–7 days |
| $0.95 (Stop) | -5% | 30% | 1–3 days |
Risks
Volatility (beta 1.15), $4.3M market cap, negative earnings (-$1.18/share), and dilution risk ($5M offering, Dec 2024). Use tight stops.
Final Thoughts
$PALI’s $1.22 pullback and $1.007 price offer a high-potential trade. Stick to the plan, monitor news, and trade smart!
Comments
Post a Comment